Drug Database
BC

BCG polysaccharide and nucleic acid injection (intramuscular) (Disu / DI SU)

✓ Approved

3SBio · 细胞治疗 · 细胞治疗

什么是 BCG polysaccharide and nucleic acid injection (intramuscular)?

BCG polysaccharide and nucleic acid injection (intramuscular) 是一种细胞治疗,由3SBio研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Disu, DI SU
公司3SBio
药物类别细胞治疗, 疫苗
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

BCG polysaccharide and nucleic acid injection (intramuscular) 针对 3 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Respiratory, thoracic and mediastinal disordersAsthma✓ Approved
Respiratory, thoracic and mediastinal disordersBronchitis chronic✓ Approved
Infections and infestationsRhinovirus infection✓ Approved

相关研究文献

PubMedAnalytical methods : advancing methods and applications2026-11-18

Single-cell analysis based on nucleic acid amplification.

He Chuchu C, Chu Chu C, Duan Zhijuan Z

In recent years, single-cell analysis has made a lot of progress, and many technologies have also emerged. Nucleic acid analysis, which is closely related to life analysis, has also been applied to single-cell detection. Technologies with nucleic acid reactions in single-cell analysis can provide invaluable insights into biological processes. In this review, we have summarized recent advances in single-cell analysis based on nucleic acid amplification, including microfluidics, fluorescence spectroscopy, electrochemical analysis and other technologies. Each method is introduced in detail. With recent developments, these technologies have opened the door for studying heterogeneity in single cells. Moreover, the technology based on nucleic acid amplification can be further developed for single-cell analysis.

PMID 43048909
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Immune Interactions Unique to Intradermal Microtoxin: Insights From Aesthetic, Therapeutic, and Vaccination Studies.

Park Je-Young JY, Parra Hernandez Luis Alberto LA, Elenany Hossam H, Kerscher Martina M et al.

Intradermal botulinum toxin type A (BoNT-A; microtoxin) has been shown to improve skin texture, superficial rhytides, and sweat/sebaceous activity through neuronal (cholinergic) and non-neuronal pathways. While discussions around immune system interactions for BoNT-A in aesthetic indications exist for intramuscular injection, the high density of antigen-presenting cells in the dermis raises the question of whether a different level of concern is warranted. This narrative review was informed by a PubMed search through 2025 identifying studies on intradermal BoNT-A and immunogenicity using combined/related terms for BoNT-A, intradermal injection, microtoxin, immunogenicity, and skin immunology. Reference lists were screened for additional studies. The number of publications on microtoxin has increased markedly since 2024. While the skin is an immunologically active organ, immunogenicity data remain limited for aesthetic intradermal injection. To date, only a single prospective study has examined immune responses to intradermal BoNT-A in aesthetic practice. This study showed higher antibody responses with intradermal versus intramuscular delivery. Like data for intramuscular injection, there is a lack of long-term data on neutralizing antibody (NAb) development; however, in the context of increasing BoNT-A doses for facial treatment and increasing long-term exposure, introduction of BoNT-A into the dermis over a large surface may raise the risk of NAb development. Microtoxin techniques may heighten immunogenic potential through dermal antigen exposure and frequent retreatment. IncobotulinumtoxinA is free of complexing proteins and has a low antigenic protein burden, which may favor its use for intradermal injection. However, direct long-term comparative evidence for aesthetic intradermal treatments is lacking.

PMID 43047073
阅读全文 →
PubMedNucleic acids research2026-11-18

Beyond the double-helix: non-canonical nucleic acid structures as drug targets and therapeutics.

Miranda André A, Oliveira Paula A PA, Mergny Jean-Louis JL, Cruz Carla C

Nucleic acids adopt a rich repertoire of non-canonical structures beyond the iconic double helix - G-quadruplexes, i-motifs, triplexes, R-loops, Z-DNA/Z-RNA, and junctions - with roles in genome stability, transcription, replication, and translation. Yet the biological evidence for these conformations varies widely, from direct in vivo validation to largely indirect biochemical inference. We organize this review around a distinctive therapeutic duality: non-canonical structures may serve as molecular targets for small molecules, peptides, and nucleic acid-based modulators, while some are also engineered as therapeutic agents in their own right. For each structural class, we critically assess structural principles, biological evidence, and detection methods, explicitly distinguishing direct in vivo validation from cell-based and biochemical observations and noting the limitations of current detection strategies. Comparing translational maturity across classes through the lens of target versus agent, we identify key challenges - structural selectivity, mechanistic attribution, target engagement, and delivery - that must be resolved to fully realize the therapeutic potential of non-canonical nucleic acid structures.

PMID 43048858
阅读全文 →
PubMedBMC emergency medicine2026-11-18

Epidemiology, outcomes, and associated factors of out-of-hospital cardiac arrest in Zhejiang, China: a province-wide registry study.

Zhao Junjie J, Li Qian Q, Tu Jianfeng J, Miao Xiaoyan X et al.

Out-of-hospital cardiac arrest (OHCA) remains a major public health challenge with poor survival worldwide. Although previous studies have described OHCA epidemiology and outcomes in China, province-wide data comprehensively characterizing patient and arrest characteristics, clinical outcomes, and factors associated with survival and neurological recovery remain limited. To characterize the epidemiology and outcomes of OHCA and identify factors associated with 30-day survival and favorable neurological outcome in Zhejiang, China. We conducted a retrospective analysis of prospectively collected data from the Zhejiang Emergency Registry (ZER), a mandatory province-wide emergency medical services (EMS) registry based on Utstein-style standardized reporting in Zhejiang, China. Adult EMS-treated OHCA cases of medical etiology between January 2024 and December 2025 were included. Patient characteristics, arrest circumstances, community response, dispatcher-related factors, EMS characteristics, prehospital interventions, and clinical outcomes were described. Multivariable logistic regression was used to identify factors associated with 30-day survival and favorable neurological outcome. Among 17,646 EMS-treated OHCA patients, 531 (3.0%) survived to 30 days and 345 (2.0%) achieved favorable neurological outcome. Bystander CPR was performed in 47.7% of cases, while dispatcher recognition of OHCA, dispatcher-assisted CPR, and bystander automated external defibrillator (AED) use occurred in 25.1%, 20.0%, and 1.8% of cases, respectively. Home arrests accounted for 64.3% of cases and had a 30-day survival rate of 2.2%. Both 30-day survival and favorable neurological outcome progressively declined with increasing EMS response time. In multivariable analysis, shockable rhythm showed the strongest association with both 30-day survival and favorable neurological outcome. Younger age, witnessed arrest, bystander CPR, bystander AED use, dispatcher recognition, dispatcher-assisted CPR, and shorter EMS response time were independently associated with improved 30-day survival. In this province-wide registry study, 30-day survival and favorable neurological outcomes after OHCA remained low in Zhejiang, China. Low rates of dispatcher recognition, dispatcher-assisted CPR, and bystander AED use were observed, and outcomes declined progressively with increasing EMS response time. Several factors were independently associated with 30-day survival and favorable neurological outcome. These findings provide population-level evidence to inform future quality-improvement strategies for OHCA care.

PMID 43046160
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Study on Safe Filler Injection Techniques Using Cutting-Edge Ultrasound Technology.

Lee Won W, Ascher Benjamin B, Yi Kyu-Ho KH, Kim Ji-Soo JS et al.

Recently, the development of an ultrasound device connected to a finger probe has enabled real-time ultrasound-guided filler injection. We aimed to evaluate the feasibility, clinical applicability, and patient satisfaction associated with the use of a novel real-time finger-held Doppler ultrasound system as a guide for hyaluronic acid filler injection. The SIBUS-IN probe was attached to the fourth finger of the left hand, and hyaluronic acid filler was injected with the right hand. A total of 33 patients underwent treatment for nasolabial folds, with an average injection of 0.98 mL (0.5-2) of Lorient No. 4 hyaluronic acid filler on the left side and 0.95 mL (0.5-1.5) of the same hyaluronic acid filler on the right side. Two weeks posttreatment, 22 out of 33 patients responded "very satisfied," while 11 patients responded "satisfied." All patients reported satisfactory results, with a mean satisfaction score of 2.67. No vascular complications were reported. The finger-held Doppler ultrasound system (SIBUS-IN) enabled real-time visualization of vascular structures during hyaluronic acid filler injection and was feasible for clinical use in nasolabial fold correction. In this limited observational cohort, the technique was well tolerated and not associated with immediate adverse events. However, the present study was not designed to demonstrate safety superiority or complication prevention; controlled comparative studies are required to determine whether this approach offers measurable advantages in safety or outcomes over conventional injection techniques. Level III.

PMID 43047035
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Weakly Ionized Interface Breaks the Poly(A) Terminal Length Constraint in Freezing Directed Spherical Nucleic Acids.

Li Guangping G, Wu Xinyue X, Wang Cheng C, Gao Heng H et al.

Non-thiolated spherical nucleic acids (SNAs) are widely used in biochemical applications, yet their synthesis remains constrained by sequence-dependent DNA adsorption onto gold nanoparticles (AuNPs). In freezing method, efficient adsorption typically requires a long poly(A) (≥10 nt), although the origin of this requirement remains unclear. Here, we show that this limitation arises primarily from the highly charged interface of citrate-stabilized AuNPs rather than the freezing process itself. Replacing citrate with weakly ionized ascorbic acid reduces interfacial electrostatic repulsion and promotes DNA adsorption, enabling stable SNAs with terminal fragments containing only two adenines (≥2 nt) and breaking the Poly(A) length limitation in freezing directed spherical nucleic acids. In this system, adenine accessibility, rather than sequence position or distal composition, governs adsorption behavior. Benefiting from the weakly ionized interfacial interactions, the resulting SNAs exhibit a high DNA packing density, imparting excellent colloidal stability (stable for 50 days in 0.1 M NaCl) and reproducible plasmonic properties (RSD = 5.1%). These findings establish interfacial interaction engineering as a general strategy for sequence-independent construction of non-thiolated SNAs.

PMID 43046419
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多BCG polysaccharide and nucleic acid injection (intramuscular)